sarscov
coronavirida
famili
identifi
etiolog
agent
sever
acut
respiratori
syndrom
sar
highli
contagi
upper
respiratori
diseas
reach
epidem
statu
pro
cystein
proteas
indispens
viral
life
cycl
identifi
one
key
therapeut
target
sar
combin
ligand
structur
base
virtual
screen
carri
asinex
platinum
collect
multipl
low
micromolar
inhibitor
enzym
identifi
search
one
also
show
activ
sarscov
whole
cell
cpe
assay
furthermor
multi
nanosecond
explicit
solvent
simul
carri
use
dock
pose
identifi
hit
studi
overal
stabil
bind
site
interact
well
identifi
import
chang
interact
profil
appar
dock
studi
cumul
analysi
evalu
compound
simul
studi
led
identif
certain
proteinligand
interact
pattern
would
use
structur
base
design
effort
sarscov
sever
acut
respiratori
syndromecoronaviru
previous
unidentifi
viru
belong
coronavirida
famili
recogn
etiolog
agent
sar
highli
infect
upper
respiratori
tract
diseas
diseas
first
diagnos
winter
amongst
patient
remot
guangdong
provinc
southern
china
highli
infecti
diseas
mortal
rate
quickli
reach
pandem
statu
spread
countri
worldwid
caus
infect
initi
symptom
diseas
similar
flu
includ
cough
sore
throat
respiratori
distress
myalgia
fever
symptom
diseas
may
appear
day
day
exposur
transmiss
may
occur
sexual
non
sexual
contact
infect
person
travel
region
identifi
local
transmiss
diseas
peak
outbreak
number
antivir
treatment
design
viral
diseas
aid
influenza
hepat
evalu
efficaci
sarscov
infect
report
treatment
patient
infect
sar
involv
isol
administr
antipyret
steroid
antivir
ribavarin
although
initi
outbreak
viru
stymi
year
first
discoveri
recent
find
report
isol
sarscov
anim
includ
chines
hors
shoe
bat
act
natur
reservoir
viru
point
possibl
anim
human
transmiss
wild
type
mutat
variant
sarscov
close
relat
corona
virus
near
futur
immin
threat
diseas
led
discoveri
number
viral
protein
could
util
possibl
target
develop
antivir
therapi
histor
evid
antivir
drug
discoveri
point
toward
number
proteas
critic
viral
replic
cycl
success
target
promin
exampl
includ
viral
proteas
hiv
human
immuno
defici
viru
proteas
hepat
c
viru
hsv
herp
simplex
viru
rhinoviru
proteas
within
viral
replic
cycl
proteas
primarili
util
either
process
high
molecular
weight
precursor
protein
produc
function
protein
b
process
structur
protein
requir
morphogenesi
assembl
viral
particl
within
coronavirida
famili
three
proteas
usual
util
fulfil
function
role
sarscov
differ
rest
member
coronavirida
famili
use
two
proteas
accomplish
function
includ
pro
papainlik
cystein
proteas
well
chymotrypsinlik
cystein
proteas
also
call
main
proteas
pro
sarscov
pro
enzym
respons
process
two
larg
replicas
polyprotein
kda
kda
function
viral
replic
transcript
process
integr
role
sarscov
lifecycl
presenc
number
apo
ligand
bound
structur
make
ideal
target
structurebas
drug
discoveri
figur
show
bind
site
pro
irrevers
peptid
inhibitor
pdb
code
bound
form
coval
michael
adduct
catalyt
cystein
shown
yellow
site
requir
hydrophob
group
ethyl
leucin
valin
respect
case
variou
flavor
natur
substrat
site
bind
glutamin
residu
far
select
requir
case
cycliz
glutamin
deriv
form
key
hydrogen
bond
side
chain
carbonyl
shown
blue
current
drug
design
effort
proteas
classifi
primarili
two
categori
peptid
molecul
reactiv
warhead
nonpeptid
small
molecul
inhibitor
peptid
ligand
usual
involv
sequenc
amino
acid
mimick
natur
substrat
enzym
attach
terminu
warhead
group
aldehyd
michael
acceptor
epoxi
keton
halomethyl
keton
etc
inhibitor
act
two
step
procedur
first
ligand
form
noncoval
micha
complex
place
warhead
group
close
proxim
catalyt
cystein
second
step
involv
attack
nucleophil
thiolat
anion
catalyt
cystein
onto
reactiv
atom
warhead
group
form
coval
adduct
inactiv
enzym
nonpeptid
small
molecul
inhibitor
form
noncoval
complex
competit
displac
enzym
substrat
bind
site
prevent
enzym
process
small
molecul
inhibitor
pro
identifi
insilico
approach
pharmacophor
search
structurebas
virtual
screen
structurebas
discoveri
well
high
throughput
screen
applic
reader
may
refer
extens
review
inhibitor
discoveri
sarscov
figur
summar
inhibitor
class
report
within
last
coupl
year
point
toward
high
level
research
interest
around
promin
antivir
target
previous
report
structurebas
virtual
screen
effort
identifi
small
molecul
inhibitor
pro
enzym
effort
result
identif
two
inhibitor
figur
micro
molar
potenc
ic
ic
origin
novel
chemic
scaffold
current
effort
focus
explor
chemic
space
around
scaffold
commerci
avail
compound
collect
result
provid
insight
proteinligand
interact
pattern
within
scaffold
establish
synthet
modif
effort
potenti
develop
toward
lead
sarscov
implement
combin
ligand
structur
base
protocol
carri
screen
exercis
aim
evalu
effect
divers
substitut
pattern
biolog
activ
preserv
core
scaffold
identifi
hit
therefor
substructur
search
becam
method
choic
ligand
base
screen
filter
substructur
search
allow
user
put
specif
constraint
natur
search
result
queri
presenc
given
substructur
within
identifi
hit
systemat
explor
activ
landscap
base
variat
specif
region
chemic
seri
question
keep
region
defin
substructur
constant
methodolog
seen
number
use
start
screen
chemic
databas
sequenti
filter
part
complex
screen
cascad
explor
immedi
chemic
space
around
identifi
hit
well
lead
optim
synthesi
ration
curtail
dataset
put
set
cascad
filter
involv
dock
use
valid
protocol
b
rank
base
combin
dock
pose
base
descriptor
dock
score
gener
final
select
molecul
biolog
evalu
sinc
dock
provid
static
snapshot
dynam
ligand
bind
process
sever
studi
suggest
use
molecular
dynam
simul
md
enhanc
understand
structur
variat
multi
bodi
complex
physiolog
condit
explicit
solvent
md
simul
bind
pose
identifi
biolog
hit
therefor
carri
help
evalu
stabil
bind
site
interact
well
identifi
perturb
interact
profil
would
possibl
dock
studi
base
analysi
substitut
pattern
observ
simul
studi
number
critic
infer
could
made
would
help
futur
structur
base
design
effort
target
asinex
platinum
collect
feb
releas
compris
molecul
use
gener
uniti
databas
within
tripo
inc
st
loui
mo
similar
search
coordin
file
sdf
format
download
submit
databas
creation
similar
search
carri
use
dbsimilar
script
selector
modul
similar
score
rang
given
queri
molecul
comput
use
tanimoto
coeffici
c
c
target
molecul
defin
bit
set
c
bit
set
common
queri
molecul
b
bit
set
defin
substructur
search
carri
use
dbsearch
command
uniti
search
modul
use
queri
gener
within
sybyl
coordin
gener
dock
select
molecul
carri
use
concord
tripo
inc
st
loui
mo
standalon
util
structur
refin
use
step
conjug
gradient
rm
converg
gasteigerhuckel
partial
charg
method
tripo
forc
field
use
minim
produc
structur
dock
dock
paramet
util
studi
valid
previous
dimer
structur
pro
pdb
code
cocrystal
coval
bound
ligand
util
dock
run
prepar
protein
dock
ligandprotein
coval
bond
delet
proton
tautom
assign
protein
carri
use
pprep
schroding
llc
portland
util
result
structur
submit
restrain
molecular
mechan
refin
use
forc
field
incorpor
impref
schroding
llc
portland
protein
structur
refin
util
final
refin
structur
use
dock
dock
carri
gold
ccdc
cambridg
uk
use
automat
ga
genet
algorithm
set
rigor
accuraci
level
b
gold
score
function
pose
rank
c
dock
constraint
supplementari
figur
three
hydrophob
constraint
defin
sphere
radiu
defin
around
centroid
heavi
atom
hydrophob
group
protein
hydrogen
bond
donor
constraint
defin
use
n
h
pose
rescor
use
consensu
score
n
max
min
refer
dock
score
given
molecul
n
maximum
minimum
score
attain
within
dock
set
molecul
given
score
function
gscore
dscore
gener
cscore
modul
sybyl
respect
dock
pose
base
descriptor
gener
silver
ccdc
cambridg
uk
use
cocrystal
ligand
pose
crystal
structur
pdb
code
consist
three
hydrophob
occup
descriptor
defin
sphere
radiu
defin
around
heavi
atom
centroid
relev
hydrophob
group
occup
sphere
volum
defin
criteria
fulfil
b
one
hydrogen
bond
donor
descriptor
defin
use
n
h
geometr
criteria
dha
angl
da
distanc
fulfil
dock
pro
complex
biolog
hit
use
perform
explicit
solvent
md
simul
parallel
desmond
molecular
dynam
system
e
shaw
research
new
york
ny
associ
analysi
tool
avail
within
schroding
suit
schroding
llc
portland
use
purpos
model
system
simul
prepar
use
system
builder
util
forc
field
paramet
assign
simul
system
inhibitorenzym
complex
place
center
cubic
box
dimens
ensur
solvent
buffer
water
molecul
solut
boundari
simul
box
direct
spc
model
use
describ
water
molecul
na
cl
ion
ad
physiolog
concentr
ensur
overal
neutral
system
solvent
molecul
overlap
solut
structur
remov
final
size
solvat
system
close
atom
crystallograph
water
retain
part
simul
system
model
system
relax
use
six
step
default
protocol
implement
desmond
util
prepar
system
productionqu
simul
relax
protocol
implement
desmond
involv
seri
minim
follow
seri
short
md
run
relax
model
system
solvat
system
first
minim
step
steepestdesc
follow
limitedmemori
broydenfletchergoldfarbshanno
lbfg
minim
maximum
step
keep
protein
ligand
atom
fix
converg
criterion
forc
constant
solut
set
kcal
mol
second
step
posit
restraint
remov
system
minim
converg
criterion
kcal
mol
use
sequenc
last
step
third
step
ps
simul
perform
use
nvt
ensembl
use
berendsen
thermostat
temperatur
k
fast
temperatur
relax
constant
ps
veloc
rescal
everi
ps
restraint
nonhydrogen
solut
atom
forc
constant
kcal
mol
next
two
short
simul
ps
perform
use
npt
ensembl
use
berendsen
barostat
maintain
pressur
atm
slow
pressur
relax
constant
ps
paramet
preserv
previou
nvt
simul
restraint
set
third
step
preserv
fourth
fifth
step
temperatur
maintain
k
fourth
step
elev
k
fifth
step
final
stage
relax
protocol
atom
set
free
simul
perform
use
npt
ensembl
simul
time
ps
use
pressur
relax
constant
ps
final
step
resembl
condit
actual
product
run
relax
system
subject
product
phase
use
npt
ensembl
period
boundari
condit
period
ns
martynatobiasklein
pressur
control
method
use
maintain
pressur
cell
bar
use
isotrop
coupl
method
nosehoov
thermostat
method
use
control
temperatur
heavi
atomhydrogen
coval
bond
constrain
use
shake
algorithm
allow
integr
step
use
integr
equat
motion
implement
accord
respa
multipl
time
step
scheme
use
simul
longrang
electrostat
forc
comput
use
smooth
particlemesh
ewald
pme
method
cutoff
distanc
calcul
shortrang
electrostat
lennardjon
interact
set
trajectori
energi
record
everi
ps
respect
glue
option
turn
proper
display
record
trajectori
conveni
structur
analysi
simul
qualiti
analysi
tool
use
analyz
energet
simul
trajectori
simul
event
analysi
tool
use
monitor
rmsd
fluctuat
hydrogen
bond
distanc
angl
vanderwa
interact
simul
trajectori
insilico
search
figur
carri
use
asinex
platinum
collect
databas
compound
compound
enumer
form
uniti
databas
use
form
hash
fingerprint
ligand
enumer
found
effect
similar
search
purpos
databas
first
filter
base
molecular
weight
let
pass
also
want
evalu
effect
similar
principl
discuss
later
abil
retriev
activ
compound
within
constraint
studi
therefor
second
stage
filter
involv
similar
search
use
two
hit
molecul
gener
two
smaller
subset
molecul
c
respect
queri
compound
third
stage
filter
involv
substructur
search
scaffold
core
two
substitut
point
r
r
defin
figur
uniqu
avail
substitut
two
point
identifi
two
curtail
subset
obtain
stage
two
subset
substitut
chosen
substitut
point
base
like
natur
interact
observ
posit
set
system
search
carri
wherein
substitut
either
r
r
posit
assign
identifi
list
substitut
variat
substitut
point
explor
addit
molecul
also
chosen
preserv
substitut
r
r
posit
modifi
core
scaffold
select
individu
search
combin
check
redund
entri
result
two
subset
molecul
two
queri
respect
follow
curtail
databas
dock
crystal
structur
pro
pdb
code
use
dock
protocol
describ
method
section
dock
score
may
lose
resolut
term
rank
order
similarli
activ
compound
still
effect
elimin
obviou
inact
compound
pose
lack
shapeinteract
complementar
bind
pocket
highli
strain
state
addit
previous
observ
use
dock
pose
base
descriptor
complement
dock
score
rank
order
pose
term
agreement
desir
pharmacophor
top
n
dock
pose
correspond
molecul
select
case
use
consensu
rank
base
dock
score
dock
pose
base
descriptor
satisfi
least
descriptor
gener
silver
final
base
overlap
core
scaffold
dock
pose
queri
compound
b
divers
substitut
r
r
posit
correspond
dock
pose
base
descriptor
c
divers
similar
queri
compound
c
commerci
avail
two
select
compound
compris
compound
made
respect
select
compound
put
sequenti
biolog
evalu
funnel
test
enzym
inhibit
potenti
antivir
activ
pro
inhibit
assay
supplementari
inform
compound
carri
two
stage
procedur
first
screen
round
involv
evalu
compound
singl
concentr
compound
show
signific
inhibit
concentr
carri
forward
next
stage
wherein
compound
evalu
use
multipl
concentr
obtain
ic
valu
doserespons
curv
amongst
evalu
compound
figur
three
seri
one
seri
show
signific
inhibit
carri
forward
doserespons
studi
compound
show
inhibit
pro
ic
two
activ
seri
show
inhibit
demonstr
ic
respect
seri
one
compound
show
inhibit
found
ic
four
compound
carri
forward
evalu
sarscov
viral
cpe
assay
supplementari
inform
show
ec
viru
infect
cell
close
enzymat
ic
correspond
ic
cytotox
normal
cell
lack
cellular
activ
activ
mayb
due
rel
higher
polar
surfac
area
higher
molecular
weight
refer
might
prevent
permeat
amount
requir
cellular
activ
particular
cellular
assay
system
base
peptid
ligand
bound
crystal
structur
figur
prefer
aliphat
hydrophob
group
site
prefer
cycliz
glutamin
deriv
ligand
carbonyl
form
critic
hydrogen
bond
interact
predict
bind
pose
identifi
hit
pro
indic
occupi
key
sub
site
molecul
figur
b
bind
manner
similar
quinazolin
core
place
catalyt
cystein
sulfur
phenyl
ring
protrud
pocket
form
hydrophob
interact
pocket
occupi
ethyl
cyclopentyl
group
cyclohexyl
case
interact
supplement
leucin
residu
p
natur
substrat
amid
side
chain
vector
pocket
wherein
carbonyl
oxygen
appear
form
hydrogen
bond
thiazol
moieti
methyl
furan
case
end
linker
may
undergo
weak
hydrophob
interact
side
chain
leu
similar
observ
made
case
two
hit
figur
c
phenyl
ring
seen
occupi
pocket
cyclohexyl
case
phenyl
ring
quinazolin
scaffold
appear
protrud
pocket
amid
side
chain
involv
critic
hydrogen
bond
interact
phenyl
ring
terminu
amid
side
chain
methyl
furan
case
may
interact
side
chain
also
possibl
termin
carboxyl
moieti
form
hydrogen
bond
side
chain
amid
flip
dock
pose
figur
e
f
predict
similar
addit
ethyl
moieti
ester
group
protrud
toward
residu
pocket
appear
form
stronger
hydrophob
interact
comparison
like
hit
ligand
figur
g
h
occupi
pocket
overal
bind
pose
similar
origin
hit
term
placement
hydrophob
group
carbonyl
oxygen
benzpyridon
moieti
form
critic
hydrogen
bond
interact
two
phenyl
side
chain
appear
occupi
site
enzym
substrat
bind
site
dimethyl
substitut
phenyl
ring
could
form
hydrophob
interact
subsit
addit
hydrogen
bond
seen
subsit
nh
group
bicycl
ring
backbon
carbonyl
oxygen
bifurc
hydrogen
bond
observ
amid
carbonyl
linker
protrud
pocket
backbon
nh
residu
form
oxyanion
hole
non
amid
side
chain
vector
pocket
chloro
substitut
phenyl
ring
occupi
site
seen
protrud
subsit
may
provid
addit
bind
affin
hydrophob
interact
case
region
occupi
methyl
phenyl
side
chain
end
amid
linker
amid
carbonyl
interact
backbon
nh
analysi
activ
inact
inhibit
structur
analogu
supplementari
figur
suggest
certain
substitut
trend
correl
activ
figur
r
posit
smaller
hydrophob
group
isobutyl
isopropyl
cyclopropyl
larg
adamantyl
group
compar
cyclohexyl
ethyl
cyclopentyl
phenyl
group
present
activ
compound
r
posit
seem
prefer
amphiphil
aryl
group
aryl
group
polar
substitut
carboxi
polar
portion
point
toward
solvent
hydrophob
portion
point
downward
pocket
possibl
interact
r
group
oxadiazol
isooxazol
thiadiazol
hydrazin
like
polar
cyclopropyl
cyclopentyl
methyl
thiophen
hydrophob
meet
requir
overal
length
r
r
substitut
subsequ
placement
termin
group
need
compat
bind
occur
case
overal
length
greater
compar
case
like
lower
compar
ideal
lead
inact
modif
dimethyl
thiophen
also
toler
similar
analysi
figur
activ
inact
compound
supplementari
figur
seri
suggest
r
group
absenc
one
carbon
linker
well
polar
substitut
termin
group
prefer
lead
inact
similarli
r
substitut
also
need
hydrophob
polar
substitut
posit
possibl
lead
lack
activ
final
met
two
top
criteria
lack
specif
dimethyl
substitut
bicycl
ring
present
activ
like
led
inact
conclus
support
md
simul
studi
discuss
later
suggest
role
stabil
benzpyridon
moieti
hydrophob
interact
similar
search
util
screen
tool
drug
discoveri
applic
two
decad
basic
premis
behind
methodolog
similar
properti
principl
state
structur
similar
molecul
share
similar
properti
thu
given
target
molecul
biolog
activ
close
neighbor
chemic
space
like
exhibit
similar
activ
profil
characterist
structur
relat
molecul
term
neighborhood
behavior
use
effici
explor
chemic
space
around
specif
molecul
attain
better
understand
structur
activityproperti
relationship
queri
molecul
well
searchabl
chemic
databas
enumer
use
specif
techniqu
fingerprint
descriptor
graph
pharmacophor
triplet
etc
similar
target
queri
molecul
usual
evalu
use
similar
metric
c
distanc
metric
euclidean
distanc
classif
compound
use
c
base
chemic
similar
util
identifi
biolog
activ
compound
evalu
extens
wide
public
studi
martin
et
al
show
select
compound
base
c
enumer
base
uniti
fingerprint
use
studi
probabl
activ
similar
assay
follow
studi
martin
et
al
howev
recalibr
probabl
cite
technic
shortcom
methodolog
well
larg
chang
activ
profil
introduc
small
structur
perturb
studi
design
reason
believ
discuss
later
within
limit
particular
applic
similar
search
ligand
base
virtual
screen
method
would
success
nonetheless
want
build
provis
enumer
compound
base
c
similar
within
screen
workflow
would
allow
us
retrospect
evalu
effect
therefor
analysi
carri
analyz
hit
count
biolog
evalu
compound
bin
base
c
similar
queri
compound
util
select
process
compound
like
like
combin
rank
base
c
similar
respect
queri
compound
bin
categori
rang
similar
seen
figur
activ
recov
bin
categori
hit
hit
rate
hit
hit
rate
hit
hit
rate
thu
use
similar
cutoff
recov
three
hit
bin
compound
share
common
core
highli
similar
c
queri
one
found
activ
correspond
hit
rate
could
number
reason
behavior
first
natur
target
solvent
expos
induc
fit
effect
around
pocket
dimer
interfac
might
make
structur
activ
landscap
complex
sensit
structur
chang
captur
use
standard
structur
similar
exampl
seri
activ
present
specif
dimethyl
substitut
addit
requir
md
simul
studi
also
point
toward
specif
role
substitut
similar
exampl
given
follow
paper
similar
search
martin
et
al
show
analogu
activ
compound
pargylin
differ
singl
methyl
group
could
lead
complet
loss
activ
similar
compar
structur
two
molecul
whole
nt
adjust
conserv
specif
area
molecul
might
weigh
toward
activ
other
given
target
therefor
molecul
core
scaffold
would
consid
similar
perspect
chemic
similar
synthet
chemistri
access
synthet
rout
markush
definit
patent
literatur
might
actual
quit
dissimilar
novel
perspect
given
target
virtu
specif
substitut
differ
secondari
reason
behavior
similar
search
could
stem
fact
queri
use
similar
search
highli
potent
might
pharmacophor
featur
requir
potent
activ
therebi
make
difficult
find
activ
base
similar
principl
md
simul
carri
investig
overal
stabil
predict
dock
pose
help
studi
conform
chang
inhibitor
rel
activ
site
result
alter
interact
profil
well
movement
amino
acid
side
chain
line
bind
site
physiolog
relev
set
overal
stabil
individu
simul
evalu
plot
total
energi
system
function
time
figur
complex
energet
stabl
maximum
fluctuat
total
energi
system
cours
simul
superposit
trajectori
onto
system
conform
start
product
phase
help
analysi
rmsd
progress
time
simul
averag
heavi
atom
rmsd
bind
site
bs
side
chain
residu
met
gln
pro
complex
respect
ns
product
phase
suggest
stabl
bind
site
ligand
pose
highli
stabl
averag
heavi
atom
rmsd
respect
figur
figur
figur
figur
ns
product
phase
averag
heavi
atom
rmsd
inhibitor
level
lower
correspond
averag
heavi
atom
rmsd
bind
site
bs
side
chain
residu
suggest
ligand
movement
rel
smaller
compar
overal
conform
chang
pro
bind
site
notic
side
chain
movement
shown
residu
solvent
expos
locat
open
catalyt
cleft
locat
domain
ii
might
explain
posit
variabl
due
inter
domain
movement
md
trajectori
repres
inhibitor
analyz
presenc
hydrogen
bond
well
hydrophob
interact
inhibitor
import
residu
enzym
bind
site
predict
dock
studi
analysi
indic
presenc
sever
hydrogen
bond
hydrophob
interact
moder
high
frequenc
occurr
sever
new
interact
observ
simul
time
cours
addit
observ
dock
suggest
possibl
consid
structur
base
design
interact
inhibitor
activ
site
residu
pro
discuss
detail
plot
md
simul
inhibitor
graphic
shown
figur
distanc
monitor
figur
use
hydrogen
bond
hydrophob
interact
shown
use
red
green
dot
line
respect
result
simul
pro
complex
shown
figur
interest
observ
made
respect
critic
hydrogen
bond
interact
sub
pocket
ns
simul
hydrogen
bond
interact
ne
subsit
enzym
amid
side
chain
carbonyl
retain
averag
da
distanc
follow
hydrogen
bond
lost
compens
new
hydrogen
bond
carbonyl
side
chain
backbon
nh
glu
locat
close
pocket
averag
da
distanc
dha
angl
ns
simul
time
figur
c
hydrophob
interact
profil
figur
show
interact
site
well
correspond
hydrophob
heavi
atom
distanc
retain
simul
time
respect
cation
pi
pi
interact
could
observ
thiazol
group
like
rel
polar
natur
aromat
group
compar
substitu
activ
end
substitut
could
also
contribut
observ
higher
movement
amid
side
chain
also
interest
note
rmsd
fluctuat
figur
show
biphas
behavior
ns
simul
show
larger
fluctuat
second
phase
correspond
hydrogen
bond
compens
event
observ
ligand
amid
side
chain
carbonyl
residu
discuss
result
simul
pro
complex
shown
figur
predict
dock
studi
amid
carbonyl
side
chain
appear
form
strong
hydrogen
bond
ne
averag
da
distanc
averag
dha
angl
figur
c
anoth
hydrogen
bond
observ
side
chain
nh
side
chain
carbonyl
oxygen
averag
da
distanc
averag
dha
angl
ns
simul
time
interact
observ
static
dock
pose
suggest
import
md
simul
detect
possibl
addit
interact
md
simul
also
reveal
new
hydrogen
bond
carboxyl
moieti
ntermin
subunit
b
averag
da
distanc
first
ns
simul
time
observ
dock
pose
addit
hydrogen
bond
interact
visavi
may
contribut
higher
affin
sub
site
exhibit
strong
hydrophob
interact
benzpyrimidin
scaffold
correspond
hydrophob
heavi
atom
distanc
simul
time
averag
distanc
sub
site
found
interact
phenyl
side
chain
correspond
hydrophob
heavi
atom
distanc
simul
time
respect
figur
e
transient
cation
pi
pi
interact
observ
phenyl
group
amid
side
chain
result
md
studi
pro
complex
shown
figur
similar
stabl
hydrogen
bond
observ
side
chain
amid
carbonyl
oxygen
ne
averag
da
distanc
averag
dha
angl
figur
c
also
transient
hydrogen
bond
observ
side
chain
oh
amid
carbonyl
oxygen
da
distanc
simul
time
residu
locat
loop
residu
involv
oxyanion
hole
format
stabil
coval
tetrahedr
intermedi
gener
substrat
hydrolysi
enzym
coincident
interact
observ
dock
pose
howev
hydrogen
bond
possibl
ethyl
ester
carboxyl
case
interact
lower
resid
time
comparison
cours
simul
sever
strong
hydrophob
interact
figur
observ
includ
interact
side
chain
hydrophob
heavi
atom
distanc
simul
time
respect
predict
dock
studi
comparison
demonstr
addit
hydrophob
interact
figur
e
ethyl
moieti
ligand
highli
stabl
cation
pi
pi
interact
observ
phenyl
ring
distanc
simul
time
addit
interact
pocket
well
transient
hydrogen
bond
interact
observ
could
account
higher
inhibitori
activ
ic
pro
comparison
activ
compound
simul
plot
pro
complex
shown
figur
multipl
hydrogen
bond
predict
base
dock
simul
figur
c
amid
carbonyl
oxygen
benzpyridon
moieti
appear
form
stabl
hydrogen
bond
ne
avg
da
distanc
avg
dha
angl
pocket
amid
nitrogen
bicycl
ring
also
form
hydrogen
bond
backbon
carbonyl
oxygen
averag
da
distanc
dha
angl
addit
amid
side
chain
form
bifurc
hydrogen
bond
backbon
amid
avg
da
distanc
avg
dha
angl
form
oxyanion
hole
stabil
coval
tetrahedr
intermedi
result
substrat
hydrolysi
enzym
hydrophob
interact
profil
complex
shown
figur
e
side
chain
interact
hydrophob
distanc
simul
time
also
exhibit
strong
interact
benzyl
side
chain
hydrophob
heavi
atom
distanc
simul
time
averag
hydrophob
heavi
atom
distanc
addit
hydrophob
interact
observ
phenyl
side
chain
b
benzpyridon
moieti
hydrophob
heavi
atom
distanc
simul
time
respect
amongst
current
hit
explor
pocket
chlorin
substitut
phenyl
ring
hydrophob
heavi
atom
distanc
progress
figur
also
show
biphas
behavior
ns
ns
suggest
possibl
stabil
interact
dimethyl
moieti
ligand
second
phase
would
turn
also
stabil
two
hydrogen
bond
pocket
form
benzpyridon
moieti
would
also
explain
activ
compound
seri
uniqu
dimethyl
substitut
phenyl
ring
benzpyridon
moieti
also
appear
engag
cation
pi
pi
interact
base
overal
analysi
certain
infer
could
made
regard
substitut
prefer
bind
proteas
may
use
structur
guid
synthesi
evalu
modif
current
avail
commerci
may
also
use
potenti
scaffold
hop
applic
first
sub
site
nt
appear
toler
polar
substitut
appear
highli
specif
hydrophob
group
may
util
occupi
subsit
smallerbulki
aliphat
group
nt
provid
adequ
hydrophob
interactioncaus
steric
clash
longer
group
requir
correspond
group
compat
size
proper
fit
phenyl
group
posit
present
activ
includ
advantag
allow
vector
packet
could
occupi
hydrophob
group
potenti
lead
increas
overal
affin
case
observ
hydrophob
chlorin
group
vector
caviti
ad
overal
stabil
bind
pose
suggest
structurebas
modif
activ
chemotyp
could
benefici
potenc
gain
furthermor
addit
smaller
hydrophob
substitu
may
use
probe
depth
pocket
likewis
site
also
prefer
phenyl
group
activ
hydrogen
bond
interact
found
moder
highli
stabl
simul
one
critic
bind
site
requir
also
support
biolog
studi
substrat
prefer
site
altern
hydrogen
bond
demonstr
backbon
lieu
oxyanion
hole
interact
observ
case
suggest
possibl
modif
vector
two
hydrogen
acceptor
eg
sulfonamid
could
util
har
addit
bind
affin
also
interest
would
hydrogen
bond
interact
observ
md
simul
addit
shown
case
hydrogen
bond
interact
backbon
residu
form
oxyanion
hole
could
form
strong
anchor
point
ligand
stabil
residu
second
monom
found
particip
transient
hydrogen
bond
interact
md
simul
may
pursu
part
structurebas
design
strategi
would
also
appear
interact
observ
dock
pose
md
simul
two
potent
hit
aliphat
hydrophob
group
may
add
overal
stabil
form
addit
hydrophob
interact
turn
help
stabil
hydrogen
bond
form
pocket
final
bind
site
appear
prefer
aryl
group
extend
pocket
critic
toward
stabil
interact
linker
end
group
locat
region
combin
ligandstructur
base
screen
carri
asinex
platinum
collect
databas
identifi
inhibitor
pro
enzym
two
previous
identifi
hit
use
carri
ligand
base
screen
follow
structur
base
screen
gener
final
select
compound
fortyfour
molecul
share
structur
similar
origin
hit
vari
substitut
select
purchas
subsequ
biolog
evalu
compound
screen
pro
enzym
use
two
stage
assay
amongst
compound
four
identifi
inhibitor
enzym
ic
rang
one
activ
also
show
activ
sarscov
viral
cpe
assay
ec
signific
sinc
till
date
small
molecul
pro
inhibitor
antivir
activ
identifi
insilico
approach
awar
one
case
cinanserin
known
serotonin
antagonist
identifi
insilico
screen
approach
report
pro
ic
ec
viral
rna
replic
assay
howev
follow
public
author
pro
ic
cinanserin
recalibr
log
order
higher
previous
report
valu
retrospect
analysi
identifi
hit
base
c
similar
respect
queri
molecul
use
ligand
base
screen
step
also
suggest
within
constraint
screen
setup
simpl
similar
search
select
compound
use
high
similar
cutoff
c
would
succeed
retriev
major
activ
compound
origin
wider
similar
window
c
bemi
murcko
suggest
use
molecular
framework
variat
mean
explor
varianc
ligandprotein
interact
profil
base
definit
test
compound
belong
compound
molecul
molecular
framework
respect
seri
current
hit
correspond
three
distinct
framework
uniqu
framework
two
origin
queri
molecul
use
identifi
comparison
identifi
hit
span
fold
term
ic
compound
found
inact
singl
point
test
concentr
help
identif
certain
substitut
trend
requir
potenc
enzym
addit
dock
pose
identifi
hit
util
seri
multi
nanosecond
simul
studi
overal
stabil
interact
profil
novel
interact
observ
dock
studi
inform
analys
would
util
structur
guid
synthesi
analogu
might
help
identif
potent
antivir
lead
target
sarscov
refer
web
version
pubm
central
supplementari
materi
compound
seri
found
demonstr
pro
activ
summari
substitut
prefer
two
scaffold
requir
activ
bin
histogram
show
count
biolog
evalu
compound
activegreen
inact
red
bin
base
similar
respect
queri
molecul
rang
similar
energi
plot
product
phase
dynam
simul
pro
complex
